Core Facts
The 5th U.S. Circuit Court of Appeals is pressing the FDA to explain why certain flavored e-cigarette products received marketing authorization while others were denied — a legal challenge that could reshape the Premarket Tobacco Product Application (PMTA) process for the entire industry.
The court’s review, initiated in early June 2026, centers on whether the FDA has applied its own standards consistently. The timing is significant: it comes just weeks after the FDA authorized Glas Inc’s fruit-flavored e-cigarettes despite data showing no statistically significant quit-smoking advantage over tobacco flavors.
The 5th Circuit’s scrutiny follows months of upheaval at the FDA, including the resignation of Commissioner Marty Makary in May over disagreements about flavored vape policy, and the departure of at least one senior official, Tracy Beth Hoeg.
Key Details
Jurisdiction: The 5th Circuit covers Texas, Louisiana, and Mississippi. A ruling here would set precedent for those states and could influence other circuits handling similar challenges.
What the court is asking: The FDA must demonstrate that its authorization decisions are based on a clear, consistent standard — not arbitrary or politically motivated. The agency has authorized some flavored products (Juul menthol, NJOY, now Glas fruit flavors) while denying thousands of others, often without detailed explanation.
The data problem: The recently released Glas memo (6 pages, compared to 90+ pages for Juul) didn’t disclose how many participants were in the study, what the confidence intervals were, or how the FDA weighed youth appeal versus adult benefit. This lack of transparency is central to the court’s concerns.
Industry context: According to tobacco monitoring data, menthol-flavored e-cigarettes now account for 30.9% of the overall e-cigarette market and 62.6% of the prefilled cartridge market. The entire flavored vape market — menthol plus fruit plus other — represents an even larger share. The court’s decision will affect billions in revenue.
Impact on Users
This case has direct implications for anyone who buys or sells flavored vaping products in the United States:
- If the court rules against the FDA: It could force the agency to either clarify its authorization standards or reopen reviews of denied applications, potentially allowing more flavored products onto the market
- If the court upholds the FDA: The current patchwork of approvals and denials stands, but with the Makary departure and data questions still unresolved, expect continued legal challenges from both industry and public health groups
- If you’re a retailer: Don’t change purchasing plans yet — this case will take months to resolve, and any ruling will likely face further appeal
- If you’re a vaper: Your access to specific products hasn’t changed today, but this case could determine what’s available a year from now
Reactions and Debate
Vape industry: Manufacturers who have been denied PMTA authorization for years see the court challenge as validation of their argument that the FDA process has been inconsistent and opaque. The fact that a company with limited data (Glas) received authorization while others with more robust studies were denied fuels this narrative.
Public health organizations: Groups including the American Lung Association and Campaign for Tobacco-Free Kids have filed amicus briefs supporting stricter review, arguing that inconsistent FDA standards have already allowed products with youth appeal onto the market.
Legal scholars: Multiple analysts note that the FDA’s shifting standards — first demanding proof of extra benefit for flavors, then authorizing fruit flavors without that proof — create a clear vulnerability under the Administrative Procedure Act, which requires agencies to follow their own rules.
Action Advice
- Industry: If you have a pending PMTA, document how your data compares to the Glas authorization standard — this may become relevant in future applications or
- Consumers: The legal landscape remains unstable — don’t stockpile based on current availability, as court rulings and state regulations can change product access quickly
- What to watch: 5th Circuit oral arguments (expected late 2026); FDA’s response brief; any congressional action on flavored vape legislation; state attorneys general responses
Continue Reading
FDA’s New Vape Enforcement Policy: Which E-Cigarettes Won’t Get Pulled | US Vape Seize and Destroy Law 2026: Federal Enforcement Explained
Kevin Li — Founder & Editor, VapeObservation.com Kevin reviews vape products hands-on, prioritizing real-world performance over manufacturer claims. His goal: honest, practical advice that helps everyday vapers make informed choices. Before launching VapeObservation, he was a longtime vaper frustrated by promotional content disguised as reviews. Every article on the site reflects his commitment to data-driven, reader-first testing.
